The comparison of GI trainees’ KPIs and pathology identified
| 2019 | 2020 | 2021 | |
| Colonoscopies performed by GI trainees | 367 | 44 | 243 |
| Sedation rates | |||
| No sedation | 28 (7.6%) | 0 (0%) | 11 (4.5%) |
| Median midazolam dose (mg) <70 years | 2.00 | 4.00 | 3.00 |
| Median midazolam dose (mg) 70 years+ | 2.00 | 2.00 | 2.00 |
| Median fentanyl dose (μg) <70 years | 50 | 50 | 50 |
| Median fentanyl dose (μg) 70yo+ | 50 | 50 | 50 |
| Bowel preparation quality | |||
| Adequate or better | 306 (83.4%) | 32 (72.7%) | 206 (84.8%) |
| Comfort score | |||
| No, minimal or mild discomfort | 341 (92.9%) | 40 (90.9%) | 231 (95.1%) |
| Other KPIs | |||
| Caecal intubation rate | 90.7% | 90.9% | 95.9% |
| Mean withdrawal time (min) | 15.83 | 17.35 | 21.36 |
| Pathology identified | |||
| ADR | 78 (21.3%) | 17 (38.6%) | 58 (23.9%) |
| ADR (including SSL) | 85 (23.2%) | 18 (40.9%) | 61 (25.1%) |
| Polyps>1 cm (% of all polyps) | 37 (11.4%) | 1 (1.6%) | 19 (10.2%) |
| Malignancy (% of procedures) | 7 (1.9%) | 3 (4.0%) | 4 (1.6%) |
ADR, adenoma detection rate; GI, gastrointestinal ; KPIs, key performance indicators; SSL, sessile serrated lesions.